Beijing Health Innovation Center Simplifies Scientist-Led Entrepreneurship; Portfolio Company ChaoMu Tech Files IPO Prospectus

Patients with Parkinson's disease experience hand tremors, while patients with nystagmus experience eye tremors. Neurosurgeons use neuroelectrical stimulation techniques to treat Parkinson's disease; could the same principle be used to treat nystagmus?

Starting from this idea, Professor Lejin Wang from the Department of Ophthalmology at Peking University People's Hospital, Professor Wensi Wang from Beijing University of Technology, and others jointly founded Super Vision Technology, Inc.

"In the past, capital had many concerns about scientists starting businesses. Because it was believed that scientists were part-time entrepreneurs, making it difficult for them to fully commit, and their grasp of the relevant commercial knowledge and skills required for entrepreneurship was rather limited." Wang Jingjing, Director of the Global Health Industry Innovation Center, introduced that the center she works for promotes...Integration of medical and engineering, providing related upstream and downstream support,Make it easier for scientists to start businesses.

Cross-disciplinary Innovation in Medical Engineering Integration

Super Vision is one of the key projects supported by the center, and has successfully achieved the transformation of scientific and technological achievements. The company's developed i-NYS Implantable Ocular Muscle Neurostimulator: the world's first Class III active implantable medical device for the treatment of congenital nystagmus, which accurately intervenes in ocular muscle nerves through neuroelectrical stimulation technology, significantly improving nystagmus symptoms and visual quality. In March 2026, the product was approved for marketing by the China National Medical Products Administration (NMPA) and received the U.S. FDA Humanitarian Use Device (HUD) designation.

Another project that the center focuses on supporting is led by Professor Zhou Anfu from the School of Computer Science at Beijing University of Posts and Telecommunications. This team has developed a non-contact millimeter-wave cardiac monitor.

"The heart, as one of the most important organs in the human body, is usually only tested for a dozen seconds during a physical examination when we do an electrocardiogram. However, some patients actually require long-term monitoring." Zhou Anfu introduced that the detection instrument developed by the team uses micro-motion monitoring technology, which was originally applied in military and transportation fields. For instance, radar installed on airplanes monitors vehicle movements on the ground, or it can be installed on vehicles to monitor other vehicles and obstacles on the road.

Reporters saw in the live demonstration that, under the detection of an instrument 1 meter away from the body, the computer screen displayed the real-time electrocardiogram and respiration monitoring curve of the human body.

Zhou Anfu introduced that the current instrument's effective monitoring distance from the human body is approximately 1 meter. In the future, when the monitoring distance is extended to 3 meters, it can be installed on the ceiling for 24-hour contactless monitoring of heart indicators.

Significant Transformation of Innovative Achievements

The Global Health Industry Innovation Center was established by the Tsinghua University Industrial Development Research Institute and serves as a proof-of-concept platform for the Global Health Industry Innovation Center. It is supported by the Beijing Municipal Science and Technology Commission.ZhongguancunThe Management Committee’s first batch of recognized projects with ongoing support. The platform has cumulatively identified over 3,820 innovative projects in medical devices, gene and cell therapy, artificial intelligence, etc., covering 80 clinical departments across 76 hospitals in China and 38 specialties across 22 universities.

The platform continuously follows up on projects, providing full-chain support for incubation and acceleration. It matches projects with comprehensive resources in technology, clinical, registration certification, industry, and capital. Through multiple measures such as incubation, investment, acceleration, and brand empowerment, it drives projects from the laboratory to the industrial end. It has cumulatively incubated and invested in 30 enterprises, including Tupai Medical, Weici Technology, Super Vision, and Xi Jian Technology, with a total project valuation exceeding 9 billion yuan.

It is reported that, for the upcoming "15th Five-Year Plan," Beijing will continue to deepen the reform of the mechanism for transforming scientific and technological achievements. It will implement the "Beijing Action Plan for Promoting the Transformation of Scientific and Technological Achievements (2025–2027)" effectively. By 2027, an efficient, collaborative, and dynamic system for transforming scientific and technological achievements will be basically established. A number of major scientific and technological achievements serving national strategic needs and meeting the requirements of Beijing's economic and social development will be successfully transformed. This plan aims to establish 1,000 cooperative platforms, facilitate 5,000 technical development cooperation projects, incubate 3,000 technology-based enterprises and 600 specialized and sophisticated enterprises, open up new tracks in future industries, achieve new alternatives in key core technologies, and stimulate new momentum for transformation and upgrading.